Sitagliptin-Mepha 25 mg
Sitagliptin-Mepha 25 mg is a medicine authorised by Swissmedic under authorisation number 66804. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 February 2018 and the authorisation is valid without a time limit. ATC code A10BH01 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 66804 |
|---|---|
| Name | Sitagliptin-Mepha 25 mg |
| Full name | Sitagliptin-Mepha 25 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BH01 |
| First authorisation | 14 February 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sitagliptin-Mepha 25 mg, Filmtabletten | B | 14 February 2018 |
| 2 | Sitagliptin-Mepha 50 mg, Filmtabletten | B | 14 February 2018 |
| 3 | Sitagliptin-Mepha 100 mg, Filmtabletten | B | 14 February 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 2 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 3 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 4 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 5 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 6 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sitagliptin-Mepha 25 mg authorised in Switzerland?
Yes. Sitagliptin-Mepha 25 mg is authorised by Swissmedic under authorisation number 66804, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sitagliptin-Mepha 25 mg have?
Sitagliptin-Mepha 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sitagliptin-Mepha 25 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.